Skip to content
CancerIndex

Publication

Promoter methylation of cyclin D2 gene in gastric carcinoma.

Authors not recorded

Int J Oncol2003PMID 14612939stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (3)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 3

Curated evidence

Evidence citing this paper (1)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
14612939
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–1 of 1 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
CCND2 PROMOTER DEMETHYLATION1
(diagnostic)Malignant Gastric NeoplasmDiagnosticDSupports Negative3accepted
EID219

CCND2 hypomethylation is seen to be more common in stage III and IV gastric tumors than stage I and II.

PMID 14612939 · Oshimo et al., 2003 · Open in CIViC

civic